Delivery Order SPE2DB22D1017-SPE2DB23FF9XT
Award Date 7/14/23
Potential Completion Date 7/17/23
Potential Value $5.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $642.93 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 20 mg RELPAX tablets. The order is for a quantity of six packages of the medication and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 25, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supply chain to support the military services and combatant commands. This small order for a...
- The Defense Logistics Agency awarded a delivery order valued at $2,748.21 to AmerisourceBergen Drug Corp for RELPAX 20 mg tablets (unit dose, 6-count packaging) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award is a child delivery order issued under AmerisourceBergen Drug Corp's parent company...
- The Defense Logistics Agency awarded a delivery order valued at $2,567.79 to AmerisourceBergen Drug Corp for the supply of Relpax 40 mg tablets in unit dose packaging (6 count). This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of June 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Relpax 20 mg tablets (unit dose, 6-count packages) with a ceiling value of $1,617.64. The order, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a firm fixed price delivery under a competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- This delivery order for $886 worth of Relpax 20 mg tablets was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation on October 13, 2023. The place of performance is Conshohocken, Pennsylvania and the completion date is October 16, 2023. No set-aside designation was used for this firm fixed price contract. The Defense Logistics Agency manages the global supply chain for the United States military and this order is likely supporting their stocking of pharmaceuticals for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,635.79 Firm Fixed Price delivery order is for the supply of 4566239879 - RELPAX 40 MG TABLET UD 6S, with a period of performance through October 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,603.58 firm fixed price delivery order is for the supply of RELPAX 40 MG TABLET UD 12S, a prescription medication, to support military healthcare programs. The award has an ultimate completion date of February 15, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,500.51 contract is for the delivery of RELPAX 40 MG TABLET UD 6S, a prescription drug medication, with a completion date of February 22, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of RELPAX 40 MG TABLET UD 6S, a prescription medication, with a ceiling value of $5,567.03 and a period of performance through September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $1,443.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the supply of 4564272271 RELPAX 40 MG TABLET UD 12S, with a completion date of April 16, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB23FF9XTDelivery Order
The Defense Logistics Agency awarded a $5,444.24 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561502479 RELPAX 40 MG TABLET UD 6S. The prime contractor, Amerisourcebergen Drug Corporation, is headquartered in Conshohocken, Pennsylvania and will fulfill the order from its facility located at the same address. Funding is provided by the Defense Logistics Agency to supply the specified pharmaceutical product in support of Department of Defense requirements. Performance is required from July 14 through July 17, 2023. No set aside designation or subcontractors are indicated.
Generated 12/24/23, 7:51 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 7/14/23 |